Literature DB >> 27014935

Pelvic Floor Muscle Training With and Without Electrical Stimulation in the Treatment of Lower Urinary Tract Symptoms in Women With Multiple Sclerosis.

Adélia Lúcio1, Carlos Arturo Levi Dʼancona, Maria Carolina Perissinotto, Linda McLean, Benito Pereira Damasceno, Maria Helena Baena de Moraes Lopes.   

Abstract

PURPOSE: The aim of this study was to evaluate the effect of intravaginal neuromuscular electrical stimulation (NMES) and transcutaneous tibial nerve stimulation (TTNS) on lower urinary tract symptoms (LUTS) and health-related quality of life in women undergoing pelvic floor muscle (PFM) training (PFMT) with multiple sclerosis (MS) and to compare the efficacy of these 2 approaches.
DESIGN: Randomized controlled trial.
METHODS: Thirty women with MS and LUTS were randomly allocated to 1 of 3 groups and received treatment for 12 weeks. Ten women in group 1 received PFMT with electromyographic (EMG) biofeedback and sham NMES. Ten women in group 2 underwent PFMT with EMG biofeedback and intravaginal NMES, and 10 subjects in group 3 received PFMT with EMG biofeedback and TTNS. Multiple assessments, performed before and after treatment, included a 24-hour pad test, 3-day bladder diary, assessment of PFM function (strength and muscle tone), urodynamic studies, and validated questionnaires including Overactive Bladder Questionnaire (OAB-V8), International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), and Qualiveen instrument.
RESULTS: All groups showed reductions in pad weight, frequency of urgency and urge urinary incontinence episodes, improvement in all domains of the PFM assessment, and lower scores on the OAB-V8 and ICIQ-SF questionnaires following treatment. Subjects in group 2 achieved significantly greater improvement in PFM tone, flexibility, ability to relax PFMs, and OAB-V8 scores when compared to subjects in groups 1 and 3.
CONCLUSION: Results suggest that PFMT alone or in combination with intravaginal NMES or TTNS is effective in the treatment of LUTS in patients with MS. The combination of PFMT and NMES offers some advantage in the reduction of PFM tone and symptoms of overactive bladder.

Entities:  

Mesh:

Year:  2016        PMID: 27014935     DOI: 10.1097/WON.0000000000000223

Source DB:  PubMed          Journal:  J Wound Ostomy Continence Nurs        ISSN: 1071-5754            Impact factor:   1.741


  7 in total

Review 1.  [What is new in symptomatic MS treatment: Part 3-bladder dysfunction].

Authors:  T Henze; W Feneberg; P Flachenecker; D Seidel; H Albrecht; M Starck; S G Meuth
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

Review 2.  The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis.

Authors:  Jure Tornic; Jalesh N Panicker
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-28       Impact factor: 5.081

3.  Effects of behavioural therapy versus interferential current on bladder dysfunction in multiple sclerosis patients; a randomised clinical study.

Authors:  Abdullah M Al-Shenqiti; Walaa M Ragab; Esraa H Rostum; Hatem A Emara; Osama A Khaled
Journal:  J Taibah Univ Med Sci       Date:  2021-09-01

Review 4.  Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis.

Authors:  Maddalena Sparaco; Simona Bonavita
Journal:  J Clin Med       Date:  2022-03-31       Impact factor: 4.241

Review 5.  Electrostimulation of the posterior tibial nerve in individuals with overactive bladder: a literature review.

Authors:  Marilia Barbosa Santos Garcia; João Santos Pereira
Journal:  J Phys Ther Sci       Date:  2018-10-12

6.  Management strategies for lower urinary tract symptoms (LUTS) among people with multiple sclerosis (MS): a qualitative study of the perspectives of people with MS and healthcare professionals.

Authors:  Hawra B Al Dandan; Rose Galvin; Doreen McClurg; Susan Coote
Journal:  HRB Open Res       Date:  2019-11-18

7.  Effects of nonsurgical, minimally or noninvasive therapies for urinary incontinence due to neurogenic bladder: a systematic review and meta-analysis.

Authors:  Mohammed Usman Ali; Kenneth Nai-Kuen Fong; Priya Kannan; Umar Muhammad Bello; Georg Kranz
Journal:  Ther Adv Chronic Dis       Date:  2022-03-18       Impact factor: 5.091

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.